Skip to main content
NCBI home page
Epidemiology and Infection logoLink to Epidemiology and Infection
. 1992 Apr;108(2):337–341. doi: 10.1017/s0950268800049803

Prevalence of serotypes of Xanthomonas maltophilia from world-wide sources.

B Schable 1, D L Rhoden 1, W R Jarvis 1, J M Miller 1
PMCID: PMC2271985  PMID: 1582474

Abstract

Since its development in 1988, a serologic typing scheme for Xanthomonas maltophilia, based on 31 O antigens, has been successfully used to serotype isolates involved in nosocomial outbreaks in the United States. To determine if this serotyping scheme would be useful in typing X. maltophilia isolates from world-wide sources, we obtained additional isolates from 10 countries; of 900 isolates tested, 795 (88.3%) were typable. In order of predominance, the three most common serotypes were 10, 3 and 19. These three serotypes were most frequently associated with respiratory and blood isolates. This serotyping system is useful as an epidemiologic screening method for universal typing of outbreaks of X. maltophilia infections.

Full text

PDF
337

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Felegie T. P., Yu V. L., Rumans L. W., Yee R. B. Susceptibility of Pseudomonas maltophilia to antimicrobial agents, singly and in combination. Antimicrob Agents Chemother. 1979 Dec;16(6):833–837. doi: 10.1128/aac.16.6.833. [DOI] [PMC free article] [PubMed] [Google Scholar]
  2. Gardner P., Griffin W. B., Swartz M. N., Kunz L. J. Nonfermentative gram-negative bacilli of nosocomial interest. Am J Med. 1970 Jun;48(6):735–749. doi: 10.1016/s0002-9343(70)80009-2. [DOI] [PubMed] [Google Scholar]
  3. Gilardi G. L. Infrequently encountered Pseudomonas species causing infection in humans. Ann Intern Med. 1972 Aug;77(2):211–215. doi: 10.7326/0003-4819-77-2-211. [DOI] [PubMed] [Google Scholar]
  4. Gilardi G. L. Pseudomonas maltophilia infections in man. Am J Clin Pathol. 1969 Jan;51(1):58–61. doi: 10.1093/ajcp/51.1.58. [DOI] [PubMed] [Google Scholar]
  5. Holmes B., Lapage S. P., Easterling B. G. Distribution in clinical material and identification of Pseudomonas maltophilia. J Clin Pathol. 1979 Jan;32(1):66–72. doi: 10.1136/jcp.32.1.66. [DOI] [PMC free article] [PubMed] [Google Scholar]
  6. Khardori N., Elting L., Wong E., Schable B., Bodey G. P. Nosocomial infections due to Xanthomonas maltophilia (Pseudomonas maltophilia) in patients with cancer. Rev Infect Dis. 1990 Nov-Dec;12(6):997–1003. doi: 10.1093/clinids/12.6.997. [DOI] [PubMed] [Google Scholar]
  7. Moody M. R., Young V. M., Kenton D. M. In vitro antibiotic susceptibility of pseudomonads other than Pseudomonas aeruginosa recovered from cancer patients. Antimicrob Agents Chemother. 1972 Nov;2(5):344–349. doi: 10.1128/aac.2.5.344. [DOI] [PMC free article] [PubMed] [Google Scholar]
  8. Morrison A. J., Jr, Hoffmann K. K., Wenzel R. P. Associated mortality and clinical characteristics of nosocomial Pseudomonas maltophilia in a university hospital. J Clin Microbiol. 1986 Jul;24(1):52–55. doi: 10.1128/jcm.24.1.52-55.1986. [DOI] [PMC free article] [PubMed] [Google Scholar]
  9. Muder R. R., Yu V. L., Dummer J. S., Vinson C., Lumish R. M. Infections caused by Pseudomonas maltophilia. Expanding clinical spectrum. Arch Intern Med. 1987 Sep;147(9):1672–1674. [PubMed] [Google Scholar]
  10. Nord C. E., Wadström T., Wretlind B. Synergistic effect of combinations of sulfamethoxazole, trimethoprim, and colistin against Pseudomonas maltophilia and Pseudomonas cepacia. Antimicrob Agents Chemother. 1974 Oct;6(4):521–523. doi: 10.1128/aac.6.4.521. [DOI] [PMC free article] [PubMed] [Google Scholar]
  11. Pedersen M. M., Marso E., Pickett M. J. Nonfermentative bacilli associated with man. 3. Pathogenicity and antibiotic susceptibility. Am J Clin Pathol. 1970 Aug;54(2):178–192. doi: 10.1093/ajcp/54.2.178. [DOI] [PubMed] [Google Scholar]
  12. Schable B., Rhoden D. L., Hugh R., Weaver R. E., Khardori N., Smith P. B., Bodey G. P., Anderson R. L. Serological classification of Xanthomonas maltophilia (Pseudomonas maltophilia) based on heat-stable O antigens. J Clin Microbiol. 1989 May;27(5):1011–1014. doi: 10.1128/jcm.27.5.1011-1014.1989. [DOI] [PMC free article] [PubMed] [Google Scholar]
  13. Schable B., Villarino M. E., Favero M. S., Miller J. M. Application of multilocus enzyme electrophoresis to epidemiologic investigations of Xanthomonas maltophilia. Infect Control Hosp Epidemiol. 1991 Mar;12(3):163–167. doi: 10.1086/646310. [DOI] [PubMed] [Google Scholar]
  14. Sutter V. L. Identification of Pseudomonas species isolated from hospital environment and human sources. Appl Microbiol. 1968 Oct;16(10):1532–1538. doi: 10.1128/am.16.10.1532-1538.1968. [DOI] [PMC free article] [PubMed] [Google Scholar]
  15. Yu V. L., Felegie T. P., Yee R. B., Pasculle A. W., Taylor F. H. Synergistic interaction in vitro with use of three antibiotics simultaneously against Pseudomonas maltophilia. J Infect Dis. 1980 Oct;142(4):602–607. doi: 10.1093/infdis/142.4.602. [DOI] [PubMed] [Google Scholar]
  16. Zuravleff J. J., Yu V. L. Infections caused by Pseudomonas maltophilia with emphasis on bacteremia: case reports and a review of the literature. Rev Infect Dis. 1982 Nov-Dec;4(6):1236–1246. doi: 10.1093/clinids/4.6.1236. [DOI] [PubMed] [Google Scholar]

Articles from Epidemiology and Infection are provided here courtesy of Cambridge University Press

RESOURCES